RA CAPITAL MANAGEMENT, L.P. Q3 2017 Filing
Filed November 14, 2017
Portfolio Value
$1.1T
Holdings
27
Report Date
Q3 2017
Filing Type
13F-HR
All Holdings (27 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | ASNDASCENDIS PHARMA A S | 5,580,690 | $202.3B | 18.28% | |
| 2 | WVEWAVE LIFE SCIENCES LTD | 7,088,651 | $154.2B | 13.93% | |
| 3 | —AVEXIS INC | 1,238,181 | $119.8B | 10.82% | |
| 4 | —BIOHAVEN PHARMACTL HLDG CO LTD | 1,997,278 | $74.7B | 6.74% | |
| 5 | —ACHILLION PHARMACEUTICALS INC | 13,633,220 | $61.2B | 5.53% | |
| 6 | —IGNYTA INC | 4,106,601 | $50.7B | 4.58% | |
| 7 | GTHXEURG1 THERAPEUTICS INC | 2,684,244 | $49.8B | 4.50% | |
| 8 | KALAKALA PHARMACEUTICALS INC | 2,113,236 | $48.3B | 4.36% | |
| 9 | —MYOVANT SCIENCES LTD | 2,830,455 | $43.8B | 3.96% | |
| 10 | —AVEO PHARMACEUTICALS INC | 11,328,646 | $41.4B | 3.74% | |
| 11 | BCRXBIOCRYST PHARMACEUTICALS | 6,984,692 | $36.6B | 3.31% | |
| 12 | —ZOGENIX INC | 992,268 | $34.8B | 3.14% | |
| 13 | IM8NINSMED INC | 722,714 | $22.6B | 2.04% | |
| 14 | —KADMON HLDGS INC | 6,666,666 | $22.3B | 2.02% | |
| 15 | —ACORDA THERAPEUTICS INC | 900,259 | $21.3B | 1.92% | |
| 16 | —IMMUNOMEDICS INC | 1,478,742 | $20.7B | 1.87% | |
| 17 | —RA PHARMACEUTICALS INC | 1,351,808 | $19.7B | 1.78% | |
| 18 | GBYSANGAMO THERAPEUTICS INC | 1,250,000 | $18.8B | 1.69% | |
| 19 | —DICERNA PHARMACEUTICALS INC | 2,428,571 | $14.0B | 1.26% | |
| 20 | —AQUINOX PHARMACEUTICALS INC | 710,682 | $10.1B | 0.91% | |
| 21 | —CLEMENTIA PHARMACEUTICALS INC COM NPV | 585,403 | $9.9B | 0.89% | |
| 22 | TGTXTG THERAPEUTICS INC | 700,000 | $8.3B | 0.75% | |
| 23 | KRYSKRYSTAL BIOTECH INC | 700,000 | $7.0B | 0.63% | |
| 24 | VNDAVANDA PHARMACEUTICALS INC | 243,971 | $4.4B | 0.39% | |
| 25 | KALVKALVISTA PHARMACEUTICALS INC | 591,070 | $4.3B | 0.39% | |
| 26 | —CHIASMA INC | 1,396,400 | $3.6B | 0.32% | |
| 27 | —PROTEON THERAPEUTICS INC | 1,337,462 | $2.7B | 0.24% |